January 10, 2017
Takeda Pharmaceutical said on January 9 that it will acquire US cancer drug maker Ariad Pharmaceuticals for roughly US$5.4 billion in a bid to beef up its oncology franchise, one of its focus fields. The Japanese drug juggernaut plans to...read more